Knight Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.223; its P/E ratio is ―; Knight Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 92.26M	$ 95.57M	$ 86.60M	$ 74.20M	$ 81.50M
Gross Profit	$ 45.02M	$ 47.34M	$ 41.70M	$ 34.22M	$ 40.18M
EBIT	$ 2.52M	$ 3.00M	$ -4.57M	$ -22.06M	$ 11.50M
EBITDA	$ 15.91M	$ 16.17M	$ 8.01M	$ -10.60M	$ 25.20M
Net Income Common Stockholders	$ 85.00K	$ -1.94M	$ -4.55M	$ -24.33M	$ 9.59M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 147.72M	$ 148.84M	$ 174.27M	$ 154.42M	$ 142.46M
Total Assets	$ 962.29M	$ 945.36M	$ 968.21M	$ 945.49M	$ 1.01B
Total Debt	$ 58.22M	$ 58.11M	$ 70.09M	$ 69.09M	$ 82.02M
Net Debt	$ -89.50M	$ -90.73M	$ -104.18M	$ -85.33M	$ -60.44M
Total Liabilities	$ 188.38M	$ 182.56M	$ 206.32M	$ 198.62M	$ 196.48M
Stockholders Equity	$ 773.91M	$ 762.80M	$ 761.89M	$ 746.87M	$ 814.66M
Cash Flow	-
Free Cash Flow	$ 2.97M	$ -18.51M	$ 19.95M	$ 18.14M	$ 14.88M
Operating Cash Flow	$ 5.02M	$ -1.09M	$ 30.88M	$ 17.94M	$ 15.17M
Investing Cash Flow	$ 11.53M	$ 11.75M	$ -24.37M	$ -1.90M	$ 35.76M
Financing Cash Flow	$ -3.93M	$ -11.36M	$ -2.90M	$ -35.70M	$ -11.24M

Currency in USD

Knight Therapeutics Earnings and Revenue History

Income Statement >

Knight Therapeutics Debt to Assets

Balance Sheet >

Knight Therapeutics Cash Flow

Cash Flow >

Knight Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing